natural history of hiv infection in infected haitians with known date of seroconversion.

NLM AIDSLINE Natural history of HIV infection in infected Haitians with known date of seroconversion. Deschamps MM; Pape JW; Jhohnson WD Jr; Division International Medicine,
January 30, 1997

Int Conf AIDS. 1996 Jul 7-12;11(2):125 (abstract no. We.C.3395). Unique Objectives: To determine the Natural History of HIV infection in heterosexual seroconverters with known date of seroconversion in Haiti. Methods: From 1987-1995, 34 individuals heterosexually active, with documented date of seroconversion were prospectively followed for the following endpoints: 1. Development of symptomatic conditions (CDC definition). 2. AIDS. 3. Death. Date of HIV seroconversion is midpoint between last HIV (-) and first HIV (+). They were evaluated clinically every 3 months with CD4 count every 6 months. Results: After a median follow up period of 42 months, 13 of 34 seroconverters (38%) become symptomatic. The median time interval between seroconversion and appearance of first symptom is 38 months. Initial manifestations were: lymphadenopathy in 4, herpes zoster in 1, fever in 2, tuberculosis in 1, weight loss in 2, prurigo in 2, fatigue in 1. Nine (9) individuals developed AIDS 52 months post seroconversion 6-85) with an I.R for AIDS of 8.2 per 100 py. Eight (8) of the seroconverters died; all died of AIDS. The time period from seroconversion to death is 76 months. CD4 cell count provides significant prognostic information as a marker of disease progression only among after 5 years of seroconversion. Conclusion: Even in Haiti where individuals are subject to malnutrition and other infections, the majority 21 (62%) of the individuals remained free of symptoms after five (5) years of infection with HIV. The development of AIDS occurs at 5.9 years of infection with an I.R of 8.2 p 100 py. of observation. Acquired Immunodeficiency Syndrome/MORTALITY HIV Infections/MORTALITY *HIV Seropositivity/MORTALITY

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response CountyCare Offers Historic Opportunity to Improve Care for People with HIV International AIDS Advocates Demand China Give $1 Billion to Global Fund Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 CountyCare Offers Historic Opportunity to Improve Care for People with HIV Lawyer: NY man at center of HIV scare not positive GLOBAL: HIV Outcomes Could Improve by Integrating Treatment of Comorbid Mental Illness UNITED STATES: How Sexual Stigma Is Undermining HIV Treatment on American Indian Reservations HHS Office for Civil Rights launches campaign to increase awareness of HIPAA rights among HIV-positive Black men Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog Living with HIV Global HIV/AIDS leaders meet in SF, Oakland Ugandan youth move to front line of HIV, maternal health fight OVER 7 MILLION PEOPLE NOW RECEIVING HIV TREATMENT IN AFRICA - UN REPORT
Information in this article was accurate in January 30, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.